These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22727183)

  • 1. Comparison of incidence and time course of neoatherosclerosis between bare metal stents and drug-eluting stents using optical coherence tomography.
    Yonetsu T; Kim JS; Kato K; Kim SJ; Xing L; Yeh RW; Sakhuja R; McNulty I; Lee H; Zhang S; Uemura S; Yu B; Kakuta T; Jang IK
    Am J Cardiol; 2012 Oct; 110(7):933-9. PubMed ID: 22727183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between degree of neointimal hyperplasia and incidence and characteristics of neoatherosclerosis as assessed by optical coherence tomography.
    Vergallo R; Yonetsu T; Uemura S; Park SJ; Lee S; Kato K; Jia H; Abtahian F; Tian J; Hu S; Lee H; McNulty I; Prasad A; Yu B; Zhang S; Porto I; Biasucci LM; Crea F; Jang IK
    Am J Cardiol; 2013 Nov; 112(9):1315-21. PubMed ID: 23891431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.
    Ko YG; Kim DM; Cho JM; Choi SY; Yoon JH; Kim JS; Kim BK; Choi D; Jang Y; Hong MK
    Int J Cardiovasc Imaging; 2012 Apr; 28(4):715-23. PubMed ID: 21656060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography-based evaluation of in-stent neoatherosclerosis in lesions with more than 50% neointimal cross-sectional area stenosis.
    Lee SY; Shin DH; Mintz GS; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    EuroIntervention; 2013 Dec; 9(8):945-51. PubMed ID: 24384291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, clinical presentation, and predictors of early neoatherosclerosis after drug-eluting stent implantation.
    Kim C; Kim BK; Lee SY; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Am Heart J; 2015 Sep; 170(3):591-7. PubMed ID: 26385044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spatial heterogeneity of neoatherosclerosis and its relationship with neovascularization and adjacent plaque characteristics: optical coherence tomography study.
    Tian J; Ren X; Uemura S; Dauerman H; Prasad A; Toma C; Jia H; Abtahian F; Vergallo R; Hu S; McNulty I; Lee H; Lee S; Yu B; Jang IK
    Am Heart J; 2014 Jun; 167(6):884-92.e2. PubMed ID: 24890539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between pre-procedural plaque morphology and patterns of in-stent neointimal hyperplasia at 1-year follow-up in patients treated with new-generation drug-eluting stents: An optical coherence tomography based analysis.
    Shi SY; Chen KL; Gu J; Xu C; Chen QR; Chen YQ; Xu T; Ke HY; Sun JH; Ye F
    J Interv Cardiol; 2018 Dec; 31(6):737-746. PubMed ID: 30251273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue coverage and neointimal hyperplasia in overlap versus nonoverlap segments of drug-eluting stents 9 to 13 months after implantation: in vivo assessment with optical coherence tomography.
    Gutiérrez-Chico JL; Räber L; Regar E; Okamura T; di Mario C; van Es GA; Windecker S; Serruys PW
    Am Heart J; 2013 Jul; 166(1):83-94. PubMed ID: 23816026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of strut thickness on neointimal atherosclerotic change over an extended follow-up period (≥ 4 years) after bare-metal stent implantation: intracoronary optical coherence tomography examination.
    Kitabata H; Kubo T; Komukai K; Ishibashi K; Tanimoto T; Ino Y; Takarada S; Ozaki Y; Kashiwagi M; Orii M; Shiono Y; Shimamura K; Hirata K; Tanaka A; Kimura K; Mizukoshi M; Imanishi T; Akasaka T
    Am Heart J; 2012 Apr; 163(4):608-16. PubMed ID: 22520527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation.
    Lee SY; Hur SH; Lee SG; Kim SW; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term coronary arterial response to biodegradable polymer biolimus-eluting stents in comparison with durable polymer sirolimus-eluting stents and bare-metal stents: five-year follow-up optical coherence tomography study.
    Kuramitsu S; Sonoda S; Yokoi H; Iwabuchi M; Nishizaki Y; Shinozaki T; Domei T; Hyodo M; Inoue K; Shirai S; Ando K; Nobuyoshi M
    Atherosclerosis; 2014 Nov; 237(1):23-9. PubMed ID: 25190308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.
    Kim S; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Cho YK; Nam CW; Hur SH; Jang Y; Hong MK
    Am J Cardiol; 2013 Jan; 111(1):1-5. PubMed ID: 23040589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neointimal tissue component assessed by tissue characterization with 40 MHz intravascular ultrasound imaging: comparison of drug-eluting stents and bare-metal stents.
    Tsujita K; Takaoka N; Kaikita K; Hokimoto S; Horio E; Sato K; Mizobe M; Nakayama N; Kojima S; Tayama S; Sugiyama S; Nakamura S; Ogawa H
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1068-74. PubMed ID: 23460385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.
    Kim JS; Hong MK; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1147-55. PubMed ID: 23153915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of below-the-knee drug-eluting stents with frequency-domain optical coherence tomography: neointimal hyperplasia and neoatherosclerosis.
    Paraskevopoulos I; Spiliopoulos S; Davlouros P; Karnabatidis D; Katsanos K; Alexopoulos D; Siablis D
    J Endovasc Ther; 2013 Feb; 20(1):80-93. PubMed ID: 23391087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable effect of optimal lipid-lowering therapy on neointimal tissue characteristics after drug-eluting stent implantation: qualitative optical coherence tomographic analysis.
    Jang JY; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Atherosclerosis; 2015 Oct; 242(2):553-9. PubMed ID: 26318104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in neointimal appearance between early and late restenosis after sirolimus-eluting stent implantation assessed by optical coherence tomography.
    Ino Y; Kubo T; Kitabata H; Ishibashi K; Tanimoto T; Matsuo Y; Shimamura K; Shiono Y; Orii M; Komukai K; Yamano T; Yamaguchi T; Hirata K; Tanaka A; Mizukoshi M; Imanishi T; Akasaka T
    Coron Artery Dis; 2013 Mar; 24(2):95-101. PubMed ID: 23363984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-stent neoatherosclerosis and tissue characteristics of restenotic lesions following implantation of second generation drug-eluting stents in unrestricted coronary lesions: Optical frequency domain imaging study.
    Sabbah M; Kadota K; El-Eraky A; Kamal HM; Abdellah AT; El Hawary A
    J Interv Cardiol; 2017 Jun; 30(3):195-203. PubMed ID: 28295660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.